Take Part in CardioSecur’s Clinical Trials

Objective

CardioSecur Active is the first mobile ECG that allows patients to independently record a 22-lead ECG, get instant feedback and provide the data immediately to their physician.

Personal MedSystem, manufacturer of CardioSecur Active, has decided to support up to 3 research projects as a part of the research funding CardioSecur Trials. The awarded researchers will receive up to 10 devices for research in the still young area of mobile health.

The aim is to support especially studies that deal with the reduction of the burden of disease and / or an improved efficiency of disease management in cardiology using mobile ECG diagnostics.

Application and award procedure

In order to apply for CardioSecur Trials, please fill out the application document. A max. four page applications is accepted until 31.12.2015, preferably electronically, submitted to the address below.

All applicants will be informed until the 21st of January 2016 about the results of the selection process. In case of a positive vote a contract will be signed between Personal MedSystems and the awarded research centers before the initiation of the research project.

Information and submission

For further questions and to submit your proposal via email please contact:

Personal MedSystems GmbH

Jessica Thür, Marketing and Customer Support

Specialist, Wilhelm-Leuschner-Straße 41 60329 Frankfurt am Main,

+49 (0) 69 907 4778 1, thuer@cardiosecur.com

Twitter: @CardioSecur